Rituximab or Zevalin – Efficacy Trial of Therapeutic Alternatives (RoZetta)
by on Friday, August 10th, 2012 | No Comments
Condition: Follicular Lymphoma
Interventions: Drug: Zevalin; Drug: Rituximab
Sponsors: Spectrum Pharmaceuticals, Inc; Spectrum Pharmaceuticals, Inc
Not yet recruiting – verified August 2012
See the article here: Rituximab or Zevalin – Efficacy Trial of Therapeutic Alternatives (RoZetta)